Characteristics of the new coronavirus infection (COVID-19) in patients with systemic sclerosis
Interest to the topic of coronavirus infection remains unabated. At the same time, there is insufficient information in the literature on the clinical course of COVID-19 in systemic sclerosis (SSc), a systemic autoimmune disease associated with high mortality.Objective: to identify the characteristi...
Saved in:
| Main Authors: | M. N. Starovoytova, O. V. Desinova, L. P. Ananieva, O. A. Koneva, L. А. Garzanova, O. B. Ovsyannikova, R. U. Shayakhmetova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2024-12-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1669 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and tolerability of rituximab in the treatment of systemic sclerosis
by: L. A. Garzanova, et al.
Published: (2023-04-01) -
Relationship between digital ulcers and severity of lung function test in systemic sclerosis over a five-year period
by: O. B. Ovsyannikova, et al.
Published: (2022-09-01) -
The use of “Acellbia” – a biosimilar of rituximab in systemic sclerosis
by: L. P. Ananyeva, et al.
Published: (2023-08-01) -
Clinical and laboratory characteristics of patients with systemic sclerosis positive for anti-ribonucleoprotein antibodies
by: R. U. Shayakhmetova, et al.
Published: (2019-11-01) -
Comparative characteristics of the main phenotypes of systemic sclerosis
by: R. U. Shayakhmetova, et al.
Published: (2020-02-01)